Brain excitability changes in the relapsing and remitting phases of multiple sclerosis: a study with transcranial magnetic stimulation
Introduction
Recent functional and imaging studies have substantially contributed to extend the concept of MS, classically regarded as a disease limited to the myelin axonal sheath. Several findings, in fact, point to a parallel involvement of neuronal components of the central nervous system (CNS) in the course of MS (Sharma et al., 2001, Chard et al., 2002, Nicot et al., 2003), and also suggest that the beneficial action of the therapy with interferon can be attributed, at least in part, to the preservation of neuronal function (Narayanan et al., 2001).
Although magnetic resonance imaging (MRI) greatly improved the early diagnosis and the functional assessment of MS, evoked potentials still play an essential role in the clinical evaluation of the disease (McDonald et al., 2001). In particular, motor-evoked potentials (MEPs) form a technique capable of exploring the neuronal function of central motor pathways and represent, therefore, a non-invasive approach to the study of the alterations involving the neuronal compartment of the brain of MS patients (Rothwell et al., 1987, Rossini et al., 1989, Schriefer et al., 1989, Smith et al., 1989, Leocani and Comi, 2000, Schmierer et al., 2002).
Studies with transcranial magnetic stimulation (TMS) have shown that, besides a significant prolongation of the central motor conduction time (CMCT), frequent abnormalities in MS patients are represented by both an increased threshold of MEP excitability and abnormal duration of central silent period (SP) (Boniface et al., 1991, Caramia et al., 1991, Petajan and White, 2000).
To our knowledge, however, a correlation between the clinical phase of the disease and cortical excitability changes occurring in MS has never been performed nor systematically tested on each hemisphere by TMS. In so doing here, we aimed at assessing the relationship between the level of cerebral excitability and the relapsing or remitting phases of MS. Defining the clinical phase of the disease through neurophysiological criteria can also yield insights into the neurobiology of MS.
Section snippets
Subjects and methods
We studied 79 drug-free patients with relapsing-remitting (RR) MS (64 females and 15 males, aged 18–55 years), who were admitted to the neurological clinic of the University of Rome ‘Tor Vergata.’ Patient characteristics are summarized in Table 1, Table 2, Table 3, with a progressive numeration that ends in Table 3. The diagnosis of RR MS was established by clinical, laboratory and MRI criteria, and matched the criteria of Poser et al., 1983, McDonald et al., 2001. In all instances, patients
Results
Details and means with SD on patients’ clinical parameters are given in tabular analysis (Table 1, Table 2, Table 3). All patients were able to perform, as required, the muscle contraction during TMS, without evident signs of tiredness or discomfort.
Transient deterioration of sensory disturbances was the most frequent type of symptom linked with the clinical relapse followed by visual (diplopia, amaurosis and nystagmus) and pyramidal disturbances. Sphincter and memory complaints were only
Discussion
The main finding of the present study is that the relapsing phase of MS is associated with cortical hyperexcitability, irrespective of the site of clinical manifestation or new plaque formation.
TMS has proven to be important for diagnosing and monitoring the progression or the functional state of many neurological diseases (for reviews see Rossini and Rossi, 1998, Hallett, 2000). In the present study we used TMS to reveal excitability changes in RRMS patients as assessed by the analysis of
Acknowledgements
We are thankful to Dr Pasqualetti for statistical advice and Dr Mark Wilson Jones for English revision.
References (51)
- et al.
Excitability changes of muscular responses to magnetic brain stimulation in patients with central motor disorders
Electroenceph clin Neurophysiol
(1991) - et al.
Distinguishing forms of generalized epilepsy using magnetic brain stimulation
Electroenceph clin Neurophysiol
(1996) - et al.
Towards a neurophysiological marker of amyotrophic lateral sclerosis as revealed by changes in cortical excitability
Electroenceph clin Neurophysiol
(1997) - et al.
The role of magnetic stimulation in the diagnosis of multiple sclerosis
J Neurol Sci
(1991) - et al.
Motor-evoked potentials in response to fatiguing grip exercise in multiple sclerosis patients
Clin Neurophysiol
(2000) - et al.
Clinical applications of motor evoked potentials
Electroenceph clin Neurophysiol
(1998) - et al.
Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical applications
Electroenceph clin Neurophysiol
(1994) - et al.
Central motor conduction studies in motor neuron disease using magnetic brain stimulation
Electroenceph clin Neurophysiol
(1989) - et al.
F responses and central motor conduction in multiple sclerosis
Electroenceph clin Neurophysiol
(1989) - et al.
Motor cortex excitability correlates with an anxiety-related personality trait
Biol Psychiatry
(2001)
Sodium channels and their genes: dynamic expression in the normal nervous system, dysregulation in disease states
Brain Res
Responses of single spinal motoneurons to magnetic brain stimulation in healthy subjects and patients with multiple sclerosis
Brain
Pharmacologic reversal of cortical hyperexcitability in patients with ALS
Neurology
Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis
Brain
Cortical excitability in amyotrophic lateral sclerosis: a clue to pathogenesis
Can J Neurol Sci
A transcranial magnetic stimulation study evaluating methylprednisolone treatment in multiple sclerosis
Acta Neurol Scand
Altered cortical excitability in obsessive-compulsive disorder
Neurology
Transcranial magnetic stimulation and the human brain
Nature
Central motor conduction time in progressive multiple sclerosis. Correlation with MRI and disease activity
Brain
Cortico-cortical inhibition in human motor cortex
J Physiol
Central motor conduction in multiple sclerosis: evaluation of abnormalities revealed by transcutaneous magnetic stimulation of the brain
J Neurol Neurosurg Psychiatry
The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis
Ann Neurol
Neurophysiological investigations in multiple sclerosis
Curr Opin Neurol
Transcranial stimulation excites virtually all motor neurons supplying the target muscle. A demonstration and a method improving the study of motor evoked potentials
Brain
On how altered glutamate homeostasis may contribute to demyelinating disease of the CNS
Adv Exp Med Biol
Cited by (97)
Long-term potentiation-like plasticity is retained during relapse in patients with Multiple Sclerosis
2023, Clinical NeurophysiologyThe interaction between metaplastic neuromodulation and fatigue in multiple sclerosis
2023, Journal of the Neurological SciencesCitation Excerpt :Inflammatory cytokines are released during relapse phase of the disease [42]. Patients tested during relapse showed reduced intracortical inhibition and shortening of the MEP silent period (representing reduced responsiveness of intracortical inhibitory circuits [14,15]. Since GABAergic transmission is influenced by both tDCS and the disease pathology, a potential role of these synapses in the failure of metaplasticity in pwMS is illuminated.
Multiple sclerosis: Inflammation, autoimmunity and plasticity
2022, Handbook of Clinical NeurologyNon-invasive brain stimulation to assess neurophysiologic underpinnings of lower limb motor impairment in multiple sclerosis
2021, Journal of Neuroscience Methods